NCT01119287View on ClinicalTrials.gov

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Dexamethasone 0.1% ophthalmic suspension

Maxidex

DRUG

Olopatadine hydrochloride 0.1% ophthalmic solution

Patanol

OTHER

Inactive ingredients, used as placebo

Tears Naturale II

Trial Locations (1)

76134

Contact Alcon Call Center For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY